Risk analysis of blood pressure changes on cardiovascular disease in Chinese population
Open Access
- 29 August 2024
- journal article
- research article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 26 (11) , 1219-1227
Abstract
The study aimed to assess the impact of changes in blood pressure on cardiovascular events in the Chinese population. It enrolled 33 179 Chinese participants aged ≥35 years (57.1% women) without CVD at baseline. BP status was defined according to the 2017 ACC/AHA hypertension guidelines. The type of BP change was defined as change in BP status from baseline to the end of follow‐up, included stable BP <130/80, <130/80 to ≥130/80, ≥130/80 to <130/80 mm Hg, persistent BP ≥130/80 mm Hg. The hazard ratio (HR) of incident CVD by change in BP category was estimated using Cox proportional hazards and Fine–Gray models. During median follow‐up of 3.17 years, 2023 CVD events occurred. Compared with BP <120/80, 120–129/<80 mm Hg at baseline (HR = 1.66, 95% CI: 1.09–2.53), 130–139/80–89 mm Hg (HR = 1.35, 95% CI: 0.94–1.95), and ≥140/90 mm Hg (HR = 2.46, 95% CI: 1.78–3.40) were risk factors for CVD. Compared with the group with stable BP <130/80 mm Hg, the risk of CVD was 1.88 (95% CI: 1.40–2.53) in the group with persistent BP ≥130/80 mm Hg and 1.40 (95% CI: 1.01–1.94) in the group of BP decreased to <130/80 mm Hg. These results showed that BP 120–129/<80, 130–139/80–89, and ≥140/90 mm Hg were associated with a high risk of CVD. Over time, persistent BP ≥130/80 mm Hg increased the risk of CVD, but a return to <130/80 mm Hg from hypertension decreased the risk of CVD.Keywords
Funding Information
- National Natural Science Foundation of China (82160639)
This publication has 26 references indexed in Scilit:
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet, 2021
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2020
- Evaluating the treatment and control of modifiable cardiovascular disease risk factors among patients with diabetes in the Inner Mongolia, China: A cross-sectional studyPreventive Medicine, 2020
- Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease EventsJAMA, 2018
- Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in LifeJAMA, 2018
- Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension GuidelineJACC, 2018
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet, 2016
- Blood Pressure Trajectories in Early Adulthood and Subclinical Atherosclerosis in Middle AgeJAMA, 2014
- Global burden of blood-pressure-related disease, 2001The Lancet, 2008
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002